Wellington Management Group
ANIP icon

Wellington Management Group’s ANI Pharmaceuticals ANIP Stock Holding History

Wellington Management Group’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$580K Sell
7,543
-354
-4% -$27.6K ﹤0.01% 1760
2025
Q4 		$623K Sell
7,897
-275
-3% -$23.8K ﹤0.01% 1793
2025
Q3 		$749K Buy
8,172
+291
+4% +$23.7K ﹤0.01% 1829
2025
Q2 		$514K Sell
7,881
-325
-4% -$21.2K ﹤0.01% 1819
2025
Q1 		$549K Buy
+8,206
New +$490K ﹤0.01% 1808
2024
Q4 		– Sell
-9,411
Closed -$561K – 1938
2024
Q3 		$561K Sell
9,411
-34,218
-78% -$2.09M ﹤0.01% 1804
2024
Q2 		$2.78M Buy
43,629
+2,899
+7% +$188K ﹤0.01% 1450
2024
Q1 		$2.82M Buy
40,730
+31,408
+337% +$1.9M ﹤0.01% 1451
2023
Q4 		$514K Buy
+9,322
New +$513K ﹤0.01% 1725
2015
Q2 		– Sell
-8,926
Closed -$559K – 2135
2015
Q1 		$559K Sell
8,926
-7,825
-47% -$476K ﹤0.01% 1961
2014
Q4 		$944K Buy
+16,751
New +$739K ﹤0.01% 1869

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group's ANIP Position: Q1 2026 in Review

Wellington Management Group reduced its ANI Pharmaceuticals (ANIP) stake by 4.5% in Q1 2026, selling an estimated $27.6K and leaving 7,543 shares worth $580K. The position accounts for ﹤0.01% of the portfolio, ranked #1760.

Wellington Management Group first reported a position in ANIP in Q4 2014 and has held it in 11 quarters since. The position peaked at $2.82M in Q1 2024. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Wellington Management Group held 7,543 shares of ANI Pharmaceuticals worth $580K as of Q1 2026.
  • Wellington Management Group sold 354 ANI Pharmaceuticals shares in Q1 2026, an estimated $27.6K.
  • ANI Pharmaceuticals made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1760 holding.
  • Wellington Management Group first reported a position in ANI Pharmaceuticals in Q4 2014 and has held it in 11 quarters since.
  • Wellington Management Group's ANI Pharmaceuticals position peaked at $2.82M in Q1 2024.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.